Israel Englander Exicure, Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.3 - $0.64 $6,831 - $14,574
-22,772 Reduced 65.43%
12,029 $3,000
Q1 2024

May 15, 2024
SELL
$0.53 - $0.84 $12,197 - $19,331
-23,014 Reduced 39.81%
34,801 $20,000
Q4 2023

Feb 14, 2024
BUY
$0.37 - $0.75 $21,391 - $43,361
57,815 New
57,815 $33,000
Q1 2023

May 15, 2023
BUY
$0.78 - $1.58 $8,285 - $16,784
10,623 New
10,623 $9,000

Others Institutions Holding XCUR

# of Institutions
2
Shares Held
287K
Call Options Held
0
Put Options Held
0
View Full List

About EXICURE, INC.

XCUR Quotes by TradingView
  • Ticker XCUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,962,580
  • Market Cap $85.6M
  • Description
  • Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...
More about XCUR
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email